This site is intended for healthcare professionals
  • Home
  • /
  • Guidelines
  • /
  • Other endocrine disorders
  • /
  • Shared Care Guidelines: Use of Gonadotrophin Relea...
Guideline

Shared Care Guidelines: Use of Gonadotrophin Releasing Hormone (GnRH) Agonists - Triptorelin

Read time: 1 mins
Last updated:1st Apr 2021
Status: Live
Shared Care Guidelines: Use of Gonadotrophin Releasing Hormone (GnRH) Agonists - Triptorelin - British Society for Paediatric Endocrinology and Diabetes (BSPED)


Treatment with GnRH agonists should always be initiated and monitored by a specialist (Consultant Paediatric Endocrinologist or Consultant Paediatrician with expertise in growth disorders) as recognised by the British Society for Paediatric Endocrinology and Diabetes (BSPED).


Read full Guideline